Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1993;88:364-371

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodeheffer, R. J.
Right arrow Articles by Inagami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodeheffer, R. J.
Right arrow Articles by Inagami, T.

Circulation, Vol 88, 364-371, Copyright © 1993 by American Heart Association


ARTICLES

Molecular forms of atrial natriuretic factor in normal and failing human myocardium

RJ Rodeheffer, M Naruse, JB Atkinson, K Naruse, JC Burnett Jr, WH Merrill, WH Frist, H Demura and T Inagami
Department of Medicine, Mayo Clinic, Rochester, Minn 55905.

BACKGROUND. Atrial natriuretic factor (ANF) is produced by myocardial tissue, and the plasma ANF concentration is known to be elevated in congestive heart failure (CHF). Data from animal models indicate that myocardial concentrations of ANF are depleted in CHF, and this has given rise to the hypothesis that CHF is characterized by depletion of stored ANF. To date, the molecular forms of ANF and their concentrations in atrial and ventricular myocardium remain poorly characterized in the normal and the failing human heart. METHODS AND RESULTS. We measured ANF concentrations in fresh tissue from failing human hearts explanted at the time of cardiac transplantation and from organ donors whose normal hearts could not be used for transplantation. We determined total ANF and alpha, beta, and gamma ANF concentrations in the right and left atrial appendages, atrial free walls, and ventricles. In normal hearts, ANF concentration in the atrial appendages was 40-fold higher than ANF in the rest of the atrial free wall and in the ventricles. In the failing hearts, atrial appendage ANF concentrations increased 5- to 10-fold, and atrial free wall ANF concentrations increased 200-fold. Analysis of molecular forms of ANF demonstrated significant increases in the gamma and beta forms in the left atrial appendage of failing hearts. alpha, beta, and gamma ANF forms were also significantly increased in right and left atrial free wall tissue from failing hearts. In addition, failing hearts were characterized by absolute and relative increases in the precursor form gamma ANF. CONCLUSIONS. These data from fresh tissues suggest that cardiac ANF stores are not decreased in severe CHF in humans; rather, chronic CHF is characterized by marked increases in atrial ANF tissue concentrations, particularly the beta and gamma ANF forms. These findings are consistent with intracellular accumulation of precursor ANF forms in severe chronic human CHF.


This article has been cited by other articles:


Home page
ChestHome page
C. Stollberger, B. Schneider, and J. Finsterer
Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism?: Anatomic, Physiologic, and Pathophysiologic Considerations
Chest, December 1, 2003; 124(6): 2356 - 2362.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Kimura, K. Takahashi, K. Totsune, Y. Muramatsu, C. Kaneko, A. D. Darnel, T. Suzuki, M. Ebina, T. Nukiwa, and H. Sasano
Expression of Urocortin and Corticotropin-Releasing Factor Receptor Subtypes in the Human Heart
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 340 - 346.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Yoshihara, T. Nishikimi, Y. Sasako, J. Kobayashi, Y. Kosakai, R. Hattori, T. Horio, S. Kitamura, H. Matsuo, T. Ohe, et al.
PRESERVATION OF THE RIGHT ATRIAL APPENDAGE IMPROVES REDUCED PLASMA ATRIAL NATRIURETIC PEPTIDE LEVELS AFTER THE MAZE PROCEDURE
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 790 - 794.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Doyama, M. Fukumoto, G. Takemura, M. Tanaka, T. Oda, K. Hasegawa, T. Inada, S. Ohtani, T. Fujiwara, H. Itoh, et al.
Expression and distribution of brain natriuretic peptide in human right atria
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1832 - 1838.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Yoshihara, T. Nishikimi, Y. Kosakai, F. Isobe, H. Matsuoka, S. Takishita, Y. Kawashima, Y. Saito, H. Matsuo, and K. Kangawa
Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure
J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 213 - 217.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. B. James, P. M. McCarthy, S. Jaalouk, E. L. Bravo, A. Betkowski, J. D. Thomas, S. Nakatani, and F. M. Fouad-Tarazi
Plasma Volume and Its Regulatory Factors in Congestive Heart Failure After Implantation of Long-term Left Ventricular Assist Devices
Circulation, April 15, 1996; 93(8): 1515 - 1519.
[Abstract] [Full Text]


Home page
CirculationHome page
K. B. James, P. M. McCarthy, J. D. Thomas, R. Vargo, R. E. Hobbs, S. Sapp, and E. Bravo
Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure
Circulation, November 1, 1995; 92(9): 191 - 195.
[Abstract] [Full Text]